KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
Last year, Swiss businesses lost CHF 365 million as a result of the fraudulent activities of their employees - in Europe the average damage incurred per case amounted to USD 1 million. KPMG investigated 348 cases of fraud in over 69 countries in a broad-based study. The copious amounts of data gathered over the course of this study made it possible to draw up an average profile of a fraudster.
Also read
Profile of a fraudster - KPMG investigated 348 cases of fraud in over 69 countries in a broad-based study. The copious amounts of data gathered over the course of this study made it possible to draw up an average profile of a fraudster.
Related links
RSS feeds
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.